Irene Rius (@ireneriusruiz) 's Twitter Profile
Irene Rius

@ireneriusruiz

ID: 1047427599843164160

calendar_today03-10-2018 10:06:14

50 Tweet

96 Followers

234 Following

Rodilla Lab_IJC (@vrodillab) 's Twitter Profile Photo

Breaking news 🗣 We are looking for a technician/lab manager to work with us at Josep Carreras Leukaemia Research Institute (IJC). More details here: carrerasresearch.org/es/laboratory-… (Thanks for RT!)

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#ActividadesConNiños 👩🏻‍🔬 Elena Senis Herrero, Irene Rius y Carmen Escudero te proponen una actividad familiar. Se trata de un taller para jóvenes investigadores e investigadoras para descubrir los mecanismos del cáncer mediante piezas de LEGO 👇 youtu.be/V2rPB5kNUxQ

Elena Senis Herrero (@elena_senis) 's Twitter Profile Photo

Hoy a los trabajadores de Vall d’Hebron Institute of Oncology (VHIO) Vall d'Hebron nos han puesto la primera dosis de la vacuna de Pfizer 💉🦠 Mi amiga Lauri! 👩🏻‍⚕️ me ha preguntado cómo funciona y le he hecho un dibujo 👇🏼

Hoy a los trabajadores de <a href="/VHIO/">Vall d’Hebron Institute of Oncology (VHIO)</a> <a href="/vallhebron/">Vall d'Hebron</a> nos han puesto la primera dosis de la vacuna de Pfizer 💉🦠 Mi amiga <a href="/Lauradpaya/">Lauri!</a> 👩🏻‍⚕️ me ha preguntado cómo funciona y le he hecho un dibujo 👇🏼
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

🗓 El 4 de febrero es el Día Mundial contra el Cáncer. 🔬 Descubre qué hace el Grupo de Factores de Crecimiento del VHIO para conocer mejor esta enfermedad. 👉 bit.ly/FCVhio #EnVHIOInvestigamosPara #DiaMundialCancer #WorldCancerDay

🗓 El 4 de febrero es el Día Mundial contra el Cáncer. 🔬 Descubre qué hace el Grupo de Factores de Crecimiento del VHIO para conocer mejor esta enfermedad.

👉 bit.ly/FCVhio

#EnVHIOInvestigamosPara #DiaMundialCancer #WorldCancerDay
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

🔝 Vall d’Hebron supera los 100 pacientes tratados con la innovadora terapia celular CART. Actualmente, ya se han tratado pacientes con linfomas B, T y leucemias agudas linfoblásticas. ➕ bit.ly/CARTVHIO #MedicinaPersonalizada

🔝 Vall d’Hebron supera los 100 pacientes tratados con la innovadora terapia celular CART. Actualmente, ya se han tratado pacientes con linfomas B, T y leucemias agudas linfoblásticas.

➕ bit.ly/CARTVHIO

#MedicinaPersonalizada
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

🗞 Directed by VHIO’s Joaquín Arribas, and first co-authored by 2 of his lab members Enrique Javier Arenas and Alex Martínez, a study in Nature Communications unveils a novel mechanism of resistance to T-cell bispecific antibodies and CAR-T targeting HER2 breast cancer: bit.ly/NatureArribasV…

Joaquín Arribas (@joaquinarribas) 's Twitter Profile Photo

Today we publish the identification of a mechanism of resistance against cancer immune therapies in Nature Communications. Congratulations to Enrique Arenas and Alex Martínez and many, many, thanks to our sponsors Instituto de Salud Carlos III (ISCIII), @aecc_es, Ausonia and The Breast Cancer Research Foundation

Today we publish the identification of a mechanism of resistance against cancer immune therapies in <a href="/NatureComms/">Nature Communications</a>. Congratulations to Enrique Arenas and Alex Martínez and many, many, thanks to our sponsors <a href="/SaludISCIII/">Instituto de Salud Carlos III (ISCIII)</a>, @aecc_es, Ausonia and <a href="/BCRFcure/">The Breast Cancer Research Foundation</a>
Jame Abraham, MD, FACP (@jamecancerdoc) 's Twitter Profile Photo

Current and Future Management of HER2-Positive #MetastaticBreastCancer ASCO Publications One of best reviews about this topic by @prat_aleix Timely for #ASCO21 OncoAlert Paolo Tarantino ascopubs.org/doi/abs/10.120…

Current and Future Management of HER2-Positive #MetastaticBreastCancer <a href="/ASCO_pubs/">ASCO Publications</a> One of best reviews about this topic by @prat_aleix Timely for #ASCO21 <a href="/OncoAlert/">OncoAlert</a> <a href="/PTarantinoMD/">Paolo Tarantino</a>  ascopubs.org/doi/abs/10.120…
César Serrano García (@drcesarcoma) 's Twitter Profile Photo

🙏 Por favor RT 🚨📢 ATENCIÓN: BUSCAMOS 🩺Médico especialista en Oncología Médica 🦴para una plaza de facultativo en #sarcoma 🏥en Vall d’Hebron Institute of Oncology (VHIO) - centro de referencia nacional y europeo 🧪y con ganas de aprender y participar en #EnsayosClínicos #Investigación ➡️vhio.net/ref-1_2022-med…

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

🗞 Published in Cancer Research Communications, a study led by VHIO’s Laura Soucek, first-authored by Daniel Massó-Vallés at VHIO spin-off PEPTOMYC, shows that MYC inhibition by Omomyc halts disease progression in metastatic breast cancer. ➕ bit.ly/VHIO-OmomycBre…

🗞 Published in <a href="/CRC_AACR/">Cancer Research Communications</a>, a study led by VHIO’s <a href="/LauraSoucek/">Laura Soucek</a>, first-authored by Daniel Massó-Vallés at VHIO spin-off <a href="/peptomyc/">PEPTOMYC</a>, shows that MYC inhibition by Omomyc halts disease progression in metastatic breast cancer.

➕ bit.ly/VHIO-OmomycBre…
Toni Celia-Terrassa (@tceliaterrassa) 's Twitter Profile Photo

So delighted to share our findings in breast cancer #immunotherapy and first study of the celiaterrassalab.com in Nature Cancer impressively performed by the PhD student Iván Pérez and co-directed with Dr. Joan Albanell patti simone @IMIM_research nature.com/articles/s4301…

César Serrano García (@drcesarcoma) 's Twitter Profile Photo

🙏Please RT 👩‍🔬Interested in embarking in an international PhD Program in a top-notched cancer institute Vall d’Hebron Institute of Oncology (VHIO) #Barcelona? Willing to do bench-to-bedside science in #GIST #sarcoma (and also have fun) with us? 👉vhio.net/sarcoma-transl… Then... apply! 👇 desarrollobl.com/vhio-academy/

🙏Please RT

👩‍🔬Interested in embarking in an international PhD Program in a top-notched cancer institute <a href="/VHIO/">Vall d’Hebron Institute of Oncology (VHIO)</a> #Barcelona?

Willing to do bench-to-bedside science in #GIST #sarcoma (and also have fun) with us?
👉vhio.net/sarcoma-transl…

Then... apply! 👇

desarrollobl.com/vhio-academy/
Tomás Pascual (@tomaspascualmd) 's Twitter Profile Photo

Some drugs with indication approved in breast cancer by the EMA and pending or rejected in Spain. ❌Pertuzumab: adjuvant HER2+ early BC ❌Neratinib: adjuvant HER2+ early BC ❌Olaparib: gmBRCA HER2- met BC ❌Talazoparib: gmBRCA HER2- met BC ❌Tucatinib: HER2+ met BC ⬇️

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

Investigadors del VHIO descobreixen com es desenvolupen diferents mecanismes de resistència en funció de les dianes emprades en els tractaments d'immunoteràpia.  ➕ bit.ly/VHIO-CEACAM5

Investigadors del VHIO descobreixen com es desenvolupen diferents mecanismes de resistència en funció de les dianes emprades en els tractaments d'immunoteràpia. 

➕ bit.ly/VHIO-CEACAM5